A keynote presentation outlined the historical foundation, current therapeutic strategies, and future directions for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
On May 16 th , 2016, Nick H. Kim, MD University of California San Diego (UCSD), Division of Pulmonary, Critical Care & Sleep Medicine delivered his keynote presentation outlining the current state of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). As the title underscores, the lecture is not simply an outline of current therapeutic strategies but is instead a blueprint detailing the historical foundation of the field, ongoing changes in clinical practice and future directions for advancement.
Anderson et al. (Fri,) conducted a review in Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). A keynote presentation outlined the historical foundation, current therapeutic strategies, and future directions for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: